Listen Now
Topics Covered
- Overview of Endometrial Cancer, including Diagnosing and Staging, in the Context of COVID-19
- Current Standard of Care
- New Treatment Approaches
- New Treatment for Metastatic Endometrial Cancer
- The Role of Precision Medicine & Targeted Treatments
- The Important Role of Clinical Trials
- How Research Increases Your Treatment Options
- Managing Side Effects, Symptoms & Pain, in the Context of COVID-19
- The Benefits of Communicating with Your Health Care Team
- The Increasing Role of Telehealth/Telemedicine Appointments to Decrease Your Exposure to COVID-19
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & Prepared Questions
- Quality-of-Life Concerns, in the Context of COVID-19
- Questions for Our Panel of Experts
Our Panel of Experts

Carolyn D. Runowicz, MD
Executive Associate Dean for Academic Affairs, Professor, Department of Obstetrics and Gynecology, Herbert Wertheim College of Medicine, Florida International University

Georgia A. McCann, MD
Associate Professor, Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Health Science Center San Antonio

Sarah E. Kerr, MD
Pathologist, Hospital Pathology Associates, P.A., Divisions of Cytopathology; Gynecologic and Perinatal Pathology; Molecular Diagnostic Lead Pathologist for Next Generation Sequencing Development and Practice, Allina Health Laboratory (A Part of Abbott Northwestern Hospital)

Kitty Silverman
Uterine Cancer Program Director, SHARE Cancer Support

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on March 23, 2021.